Synopsys, Inc. $SNPS Holdings Decreased by SG Americas Securities LLC

SG Americas Securities LLC lowered its stake in Synopsys, Inc. (NASDAQ:SNPS) by 83.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 6,234 shares of the semiconductor company’s stock after selling 31,028 shares during the quarter. SG Americas Securities LLC’s holdings in Synopsys were worth $3,076,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Stanley Laman Group Ltd. increased its stake in shares of Synopsys by 542.9% in the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock worth $6,353,000 after acquiring an additional 10,874 shares during the last quarter. Symphony Financial Ltd. Co. grew its stake in Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after purchasing an additional 39,395 shares in the last quarter. Bank of New York Mellon Corp increased its position in Synopsys by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock worth $691,035,000 after purchasing an additional 4,815 shares during the last quarter. Westbourne Investments Inc. purchased a new stake in shares of Synopsys during the 2nd quarter worth about $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Synopsys by 1.7% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock worth $91,660,000 after purchasing an additional 2,991 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Activity

In other Synopsys news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Wednesday, January 7th. The stock was sold at an average price of $510.00, for a total value of $127,500.00. Following the transaction, the insider directly owned 12,209 shares of the company’s stock, valued at $6,226,590. The trade was a 2.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.62% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Bank of America raised Synopsys from an “underperform” rating to a “neutral” rating and lowered their price target for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Needham & Company LLC boosted their target price on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. BNP Paribas started coverage on shares of Synopsys in a report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. Piper Sandler reduced their price objective on shares of Synopsys from $630.00 to $602.00 and set an “overweight” rating for the company in a research note on Thursday, December 11th. Finally, Wells Fargo & Company increased their target price on shares of Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 11th. Ten investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $559.43.

Synopsys Price Performance

NASDAQ SNPS opened at $533.42 on Tuesday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a fifty day simple moving average of $446.82 and a 200 day simple moving average of $504.96. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The company has a market cap of $102.05 billion, a P/E ratio of 66.76, a P/E/G ratio of 4.37 and a beta of 1.12.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the business earned $3.40 EPS. The business’s revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, sell-side analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.